SEER, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price
SEER, INC. (SEER) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price of $3.11 per share as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Notes › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice · last filed 2026-08-11
- 2026-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price $3.11.
- 2026-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price $3.35.
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price $3.33.
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price $3.18.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price |
|---|---|
| 2026-06-30 | $3.11 10-Q · filed 2026-08-11 |
| 2026-03-31 | $3.35 10-Q · filed 2026-05-13 |
| 2025-12-31 | $3.33 10-K · filed 2026-03-02 |
| 2025-09-30 | $3.18 10-Q · filed 2025-11-06 |
| 2025-06-30 | $3.31 10-Q · filed 2025-08-06 |
| 2025-03-31 | $3.20 10-Q · filed 2025-05-13 |
| 2024-12-31 | $3.34 10-K · filed 2025-03-03 |
| 2024-09-30 | $8.68 10-Q · filed 2024-11-06 |
| 2024-06-30 | $8.74 10-Q · filed 2024-08-08 |
| 2024-03-31 | $8.82 10-Q · filed 2024-05-08 |
| 2023-12-31 | $8.88 10-K · filed 2024-03-04 |
| 2023-09-30 | $8.82 10-Q · filed 2023-11-07 |
| 2023-06-30 | $8.80 10-Q · filed 2023-08-08 |
| 2023-03-31 | $8.76 10-Q · filed 2023-05-09 |
| 2022-12-31 | $8.11 10-K · filed 2023-03-06 |
| 2022-09-30 | $7.58 10-Q · filed 2022-11-08 |
| 2022-06-30 | $8.74 10-Q · filed 2022-08-09 |
| 2022-03-31 | $8.43 10-Q · filed 2022-05-06 |
| 2021-12-31 | $5.32 10-K · filed 2022-03-01 |
| 2021-09-30 | $3.63 10-Q · filed 2021-11-09 |
| 2021-06-30 | $3.44 10-Q · filed 2021-08-12 |
| 2021-03-31 | $2.44 10-Q · filed 2021-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |